ADP-induced platelet shape change: An investigation of the signalling pathways involved and their dependence on the method of platelet preparation

Platelets

Volumn 11, Issue 5, 2000, Pages 286-295

  Wilde, J I ^a   Retzer, M ^a   Siess, W ^a   Watson, S P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

ADP; Platelet shape change; Rho kinase

Indexed keywords

ADENOSINE DIPHOSPHATE; CALCIUM; CALCIUM CHELATING AGENT; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; MYOSIN LIGHT CHAIN KINASE INHIBITOR; PURINE P2Y RECEPTOR; RECEPTOR SUBUNIT; RHO KINASE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; KINETICS; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE SHAPE;

ANIMALIA; MURINAE;

EID: 0033835125     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100050129305     Document Type: Article

References (43)

1. Purinergic receptors on blood platelets
2. Activation of receptor operated channels via P(2x1) not P(2T) purinoreceptors in human platelets
3. Molecular basis for ADP-induced platelet activation, II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilisation and shape change in platelets
4. Molecular basis for ADP-induced platelet activation, I. Evidence for three distinct ADP receptors on human platelets
5. P2Y1-Receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors
6. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation
7. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel
8. Role of P2Y1 purinoreceptor in ADP-induced platelet activation
9. Functional characterisation of platelet ADP-receptors
10. Identification of competitive antagonists of the P2Y1 receptor
11. FPL 66096: A novel, highly potent and selective antagonist at human platelet P2T-purinoreceptors
12. Molecular mechanisms of platelet activation
13. Regulation of platelet function by the cytoskeleton
14. Evidence for a role of myosin phosphorylation in the initiation of the platelet shape change response
15. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)
16. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)
17. Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells
18. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation
19. Regulation of myosin phosphatase through phosphorylation of the myosin-binding subunit in platelet activation
20. Agonist-induced regulation of myosin phosphatase in human platelets through activation of Rho-kinase
21. Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact platelets
22. Calcium sensitisation of smooth muscle mediated by a Rho-associated protein kinase in hypertension
23. A rho-gene product in human blood platelets. II. Effects of the ADP-ribosylation by botulinum C3-ADP ribosyltransferase on platelet aggregation
24. Activation of G(12)/G(13) results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets
25. 13
26. 13
27. 12 induced cytoskeletal responses
28. Defective platelet activation in G(αq)-deficient mice
29. The F(c) receptor-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen
30. Tyrosine phosphorylation of the Fc receptor γ-chain in collagen-stimulated platelets
31. Rapid reactions of platelets studied by a quenched flow approach: Aggregation kinetics
32. Lipid products of phosphoinositide-3-kinase and phosphatidylinositol 4',5'-bisphosphate are both required for ADP-dependent platelet spreading
33. A collagen-related peptide regulates phospholipase Cγ2 via phosphatidylinositol 3-kinase in human platelets
34. Roles of myosin light-chain kinase in platelet shape change and aggregation
35. Prostaglandin El and dibutyryl cyclic AMP enhance platelet resistance to deformation
36. 2+-independent mechanism
37. Possible involvement of protein-tyrosine kinases such as p72(syk) in the disc-sphere shape change response of porcine platelets
38. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association
39. Phosphorylation of vimentin by Rho-associated kinase at a unique amino terminal site that is specifically phosphorylated during cytokinesis
40. Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility
41. G proteins of the G(12) family are activated via thromboxane A(2) and thrombin receptors in human platelets
42. 2+ release by cAMP-dependent protein kinase. A mechanism for agonist specific calcium signalling?
43. cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROK